BMRN - BioMarin Pharmaceutical Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$87.40
DETAILS
HIGH:
$120.00
LOW:
$50.00
MEDIAN:
$84.00
CONSENSUS:
$87.40
UPSIDE:
47.61%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Halvorsen | 7,062,077 | $398.9M | 1.1% | +1,025,141 | INCREASED |
| Cooperman | 282,460 | $16.0M | 0.0% | +222,460 | INCREASED |
| Dalio | 206,911 | $11.7M | 0.1% | -23,050 | DECREASED |
| Greenblatt | 174,091 | $9.8M | 0.0% | -95,420 | DECREASED |
| Wood | 100,000 | $5.6M | 0.0% | -338,817 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-06-02 | Countouriotis Athena | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | Walbert Timothy P | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | Ho Maykin | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | Enyedy Mark J | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | Dere Willard H | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | CLARK IAN T | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | HOMBACH ROBERT J. | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | Bodem Barbara W. | director | A-Award | 7,490 | -- | -- |
| 2026-06-02 | ANDERSON ELIZABETH M | director | A-Award | 7,490 | -- | -- |
| 2026-05-20 | Hubbard Cristin | officer: EVP, Chief Commercial Officer | F-InKind | 2,318 | $50.20 | $116K |
| 2026-05-07 | Friberg Gregory R | officer: EVP, Chief R&D Officer | SELL | 3,281 | $53.85 | $177K |
| 2026-03-17 | Mueller Brian | officer: EVP, Chief Financial Officer | F-InKind | 2,117 | $56.05 | $119K |
| 2026-03-18 | Davis George Eric | officer: EVP, Chief Legal Officer | F-InKind | 1,273 | $56.05 | $71K |
| 2026-03-17 | Guyer Charles Greg | officer: EVP, Chief Technical Officer | F-InKind | 1,693 | $56.05 | $95K |
| 2026-03-17 | Hardy Alexander | director, officer: Chief Executive Officer | F-InKind | 4,252 | $56.05 | $238K |
| 2026-03-17 | Friberg Gregory R | officer: EVP, Chief R&D Officer | F-InKind | 1,629 | $56.05 | $91K |
| 2026-03-16 | Friberg Gregory R | officer: EVP, Chief R&D Officer | A-Award | 45,600 | $57.43 | $2.6M |
| 2026-03-16 | Hubbard Cristin | officer: EVP, Chief Commercial Officer | A-Award | 15,410 | -- | -- |
| 2026-03-17 | Hubbard Cristin | officer: EVP, Chief Commercial Officer | F-InKind | 1,245 | $56.05 | $70K |
| 2026-03-16 | Hubbard Cristin | officer: EVP, Chief Commercial Officer | A-Award | 36,680 | $57.43 | $2.1M |
| 2026-03-16 | Friberg Gregory R | officer: EVP, Chief R&D Officer | A-Award | 19,150 | -- | -- |
| 2026-03-16 | Guyer Charles Greg | officer: EVP, Chief Technical Officer | A-Award | 35,680 | $57.43 | $2.0M |
| 2026-03-13 | Hardy Alexander | director, officer: Chief Executive Officer | F-InKind | 2,941 | $58.51 | $172K |
| 2026-03-13 | Guyer Charles Greg | officer: EVP, Chief Technical Officer | F-InKind | 9,109 | $58.51 | $533K |
| 2026-03-16 | Davis George Eric | officer: EVP, Chief Legal Officer | F-InKind | 7,177 | $58.51 | $420K |